ISIN | LU2492015610 |
---|---|
Valorennummer | 120608809 |
Bloomberg Global ID | |
Fondsname | Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating |
Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fondsanbieter | Kieger AG |
Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
Besonderheiten |
Aktueller Preis * | 91.11 CHF | 31.07.2025 |
---|---|---|
Vorheriger Preis * | 93.90 CHF | 30.07.2025 |
52 Wochen Hoch * | 113.50 CHF | 30.08.2024 |
52 Wochen Tief * | 91.11 CHF | 31.07.2025 |
NAV * | 91.11 CHF | 31.07.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 173'214'118 | |
Anteilsklassevermögen *** | 1'009'471 | |
Trading Information SIX |
YTD-Performance | -5.96% |
31.12.2024 - 31.07.2025
31.12.2024 31.07.2025 |
---|---|---|
1 Monat | -5.65% |
30.06.2025 - 31.07.2025
30.06.2025 31.07.2025 |
3 Monate | -7.33% |
30.04.2025 - 31.07.2025
30.04.2025 31.07.2025 |
6 Monate | -12.34% |
31.01.2025 - 31.07.2025
31.01.2025 31.07.2025 |
1 Jahr | -15.24% |
31.07.2024 - 31.07.2025
31.07.2024 31.07.2025 |
2 Jahre | -9.51% |
31.07.2023 - 31.07.2025
31.07.2023 31.07.2025 |
3 Jahre | -8.89% |
04.08.2022 - 31.07.2025
04.08.2022 31.07.2025 |
5 Jahre | - | - |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 6.66% | |
---|---|---|
Abbott Laboratories | 5.64% | |
AstraZeneca PLC | 5.38% | |
Novartis AG Registered Shares | 5.33% | |
Roche Holding AG | 4.81% | |
UnitedHealth Group Inc | 4.61% | |
Boston Scientific Corp | 3.77% | |
Vertex Pharmaceuticals Inc | 3.66% | |
Intuitive Surgical Inc | 3.42% | |
Novo Nordisk AS Class B | 3.39% | |
Letzte Daten-Aktualisierung | 30.04.2025 |
TER | |
---|---|
Datum TER | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 1.05% |
SRRI ***
|
|
Datum SRRI *** | 30.04.2024 |